The molecular mechanisms underlying the down-regulation of KCa1.1 through the VDR signaling pathway in breast cancer cells has yet to be elucidated; however, epigenetic modifications and protein degradation via proteasome pathways represent possible mechanisms. This evidence concerns the gene VDR and breast carcinoma.